Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Zimmer Biomet buys non-drug pain relief system from Pacira for up to $140M

Zimmer Biomet buys non-drug pain relief system from Pacira for up to $140M

July 1, 2026Posted inMedical Technology

Pacira BioSciences offloaded its cold-therapy pain relief device to medtech orthopedics specialist Zimmer Biomet in a deal valued at up to $140 million.

Post navigation

Previous Post
Ipsen gets the Memo, penning €700M deal to buy rare disease biotech for clinical-stage asset
Next Post
Tubulin Cofactor B Drives Glioblastoma Cell Migration tubulin-cofactor-b-drives-glioblastoma-cell-migration

Recent Posts

  • StockWatch: Novartis Loses More than Market Value After Phase III Failure
  • GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times
  • Therapeutic Family Camps Bring Healing and Hope to Aboriginal Children in Remote Australia
  • AI Assistant That Reads Your Voice Makes Virtual Lab Work Feel More Human
  • Your Jawbone Could Reveal Your Sex With Over 90 Percent Accuracy, New Study Shows

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top